Mayne Pharma Group Ltd (ASX:MYX)’s stock price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.61 and traded as low as $0.50. Mayne Pharma Group shares last traded at $0.51, with a volume of 4,544,331 shares traded.
The company has a market cap of $799.39 million and a P/E ratio of -2.66. The company has a 50 day moving average price of A$0.49 and a 200-day moving average price of A$0.61. The company has a quick ratio of 1.64, a current ratio of 2.23 and a debt-to-equity ratio of 36.47.
Mayne Pharma Group Company Profile (ASX:MYX)
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products worldwide. It operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The company also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers.
Further Reading: What is an overbought condition?
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.